Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Pingjun Chen"'
Autor:
Sheeba J. Sujit, Muhammad Aminu, Tatiana V. Karpinets, Pingjun Chen, Maliazurina B. Saad, Morteza Salehjahromi, John D. Boom, Mohamed Qayati, James M. George, Haley Allen, Mara B. Antonoff, Lingzhi Hong, Xin Hu, Simon Heeke, Hai T. Tran, Xiuning Le, Yasir Y. Elamin, Mehmet Altan, Natalie I. Vokes, Ajay Sheshadri, Julie Lin, Jianhua Zhang, Yang Lu, Carmen Behrens, Myrna C. B. Godoy, Carol C. Wu, Joe Y. Chang, Caroline Chung, David A. Jaffray, Ignacio I. Wistuba, J. Jack Lee, Ara A. Vaporciyan, Don L. Gibbons, John Heymach, Jianjun Zhang, Tina Cascone, Jia Wu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract While we recognize the prognostic importance of clinicopathological measures and circulating tumor DNA (ctDNA), the independent contribution of quantitative image markers to prognosis in non-small cell lung cancer (NSCLC) remains underexplor
Externí odkaz:
https://doaj.org/article/8ee2d864530b4ff5bcd6763fb81cd4af
Autor:
Lingzhi Hong, Muhammad Aminu, Shenduo Li, Xuetao Lu, Milena Petranovic, Maliazurina B. Saad, Pingjun Chen, Kang Qin, Susan Varghese, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Amy Spelman, Yasir Y. Elamin, Marcelo V. Negrao, Ferdinandos Skoulidis, Carl M. Gay, Tina Cascone, Saumil J. Gandhi, Steven H. Lin, Percy P. Lee, Brett W. Carter, Carol C. Wu, Mara B. Antonoff, Boris Sepesi, Jeff Lewis, Don L. Gibbons, Ara A. Vaporciyan, Xiuning Le, J. Jack Lee, Sinchita Roy-Chowdhuri, Mark J. Routbort, Justin F. Gainor, John V. Heymach, Yanyan Lou, Jia Wu, Jianjun Zhang, Natalie I. Vokes
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Immune checkpoint inhibitors with or without chemotherapy are now standard of care for non-small cell lung cancer. However, the benefits of combination vs sequential therapy have not been fully explored. Here, the authors analysed 1,133 patient recor
Externí odkaz:
https://doaj.org/article/8e4eb1b2cf4847c68859d771395453bd
Autor:
Maliazurina B Saad, PhD, Lingzhi Hong, MD, Muhammad Aminu, MD, Natalie I Vokes, MD, Pingjun Chen, PhD, Morteza Salehjahromi, PhD, Kang Qin, MD, Sheeba J Sujit, PhD, Xuetao Lu, PhD, Elliana Young, MS, Qasem Al-Tashi, PhD, Rizwan Qureshi, PhD, Carol C Wu, ProfMD, Brett W Carter, ProfMD, Steven H Lin, ProfMD, Percy P Lee, ProfMD, Saumil Gandhi, MD, Joe Y Chang, ProfMD, Ruijiang Li, PhD, Michael F Gensheimer, MD, Heather A Wakelee, ProfMD, Joel W Neal, MD, Hyun-Sung Lee, MD, Chao Cheng, PhD, Vamsidhar Velcheti, ProfMD, Yanyan Lou, MD, Milena Petranovic, MD, Waree Rinsurongkawong, PhD, Xiuning Le, MD, Vadeerat Rinsurongkawong, PhD, Amy Spelman, PhD, Yasir Y Elamin, MD, Marcelo V Negrao, MD, Ferdinandos Skoulidis, MD, Carl M Gay, MD, Tina Cascone, MD, Mara B Antonoff, MD, Boris Sepesi, MD, Jeff Lewis, BS, Ignacio I Wistuba, ProfMD, John D Hazle, ProfPhD, Caroline Chung, MD, David Jaffray, ProfPhD, Don L Gibbons, ProfMD, Ara Vaporciyan, ProfMD, J Jack Lee, ProfPhD, John V Heymach, ProfMD, Jianjun Zhang, MD, Jia Wu, PhD
Publikováno v:
The Lancet: Digital Health, Vol 5, Iss 7, Pp e404-e420 (2023)
Summary: Background: Only around 20–30% of patients with non-small-cell lung cancer (NCSLC) have durable benefit from immune-checkpoint inhibitors. Although tissue-based biomarkers (eg, PD-L1) are limited by suboptimal performance, tissue availabil
Externí odkaz:
https://doaj.org/article/0a63dfd25a6f4694ab5c9c636dd7ce6b
Publikováno v:
BMC Bioinformatics, Vol 20, Iss 1, Pp 1-16 (2019)
Abstract Background Nucleus or cell detection is a fundamental task in microscopy image analysis and supports many other quantitative studies such as object counting, segmentation, tracking, etc. Deep neural networks are emerging as a powerful tool f
Externí odkaz:
https://doaj.org/article/a5b9c51379f740aeb1b2ffd06d10d9ca
Publikováno v:
BMC Bioinformatics, Vol 20, Iss 1, Pp 1-1 (2019)
Following publication of the original article [1], we have been notified of a few errors in the html version:
Externí odkaz:
https://doaj.org/article/ebcd3d65404941209454b642571139fc
Publikováno v:
In Journal of Constructional Steel Research January 2025 224 Part A
Autor:
Kinza Rohail, Saba Bashir, Hazrat Ali, Tanvir Alam, Sheheryar Khan, Jia Wu, Pingjun Chen, Rizwan Qureshi
Publikováno v:
Computer Vision – ACCV 2022 Workshops ISBN: 9783031270659
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e7eeb0aeafba74a8cde626705504c67
https://doi.org/10.1007/978-3-031-27066-6_7
https://doi.org/10.1007/978-3-031-27066-6_7
Autor:
L. Jeffrey Medeiros, Siba El Hussein, David A. Jaffray, Ignacio I. Wistuba, Joseph D. Khoury, Pingjun Chen, Jia Wu
Publikováno v:
J Pathol
Artificial intelligence-based tools designed to assist in the diagnosis of lymphoid neoplasms remain limited. The development of such tools can add value as a diagnostic aid in the evaluation of tissue samples involved by lymphoma. A common diagnosti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e74cbfb21f2e37d75f5a93ce7264ae
https://doi.org/10.1002/path.5795
https://doi.org/10.1002/path.5795
Autor:
Muhammad, Aminu, Divya, Yadav, Lingzhi, Hong, Elliana, Young, Paul, Edelkamp, Maliazurina, Saad, Morteza, Salehjahromi, Pingjun, Chen, Sheeba J, Sujit, Melissa M, Chen, Bradley, Sabloff, Gregory, Gladish, Patricia M, de Groot, Myrna C B, Godoy, Tina, Cascone, Natalie I, Vokes, Jianjun, Zhang, Kristy K, Brock, Naval, Daver, Scott E, Woodman, Hussein A, Tawbi, Ajay, Sheshadri, J Jack, Lee, David, Jaffray, D Code Team, Carol C, Wu, Caroline, Chung, Jia, Wu
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 275
Objectives: Cancer patients have worse outcomes from the COVID-19 infection and greater need for ventilator support and elevated mortality rates than the general population. However, previous artificial intelligence (AI) studies focused on patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9abb0a290ed7bf1a8b667e61e7a4524
https://pubmed.ncbi.nlm.nih.gov/36612278
https://pubmed.ncbi.nlm.nih.gov/36612278
Publikováno v:
21st century pathology. 2(3)
Immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of many malignancies. For instance, in lung cancer, however, only 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95e34dd28cc11c26dcf86197520023e4
https://pubmed.ncbi.nlm.nih.gov/36282981
https://pubmed.ncbi.nlm.nih.gov/36282981